Evaluation of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarker in different subtypes of breast cancer treated with neoadjuvant therapy - A metaanalysis of 3771 patients

被引:13
作者
Denkert, C.
von Minckwitz, G.
Darb-Esfahani, S.
Heppner, B. Ingold
Klauschen, F.
Furlanetto, J.
Pfitzner, B.
Huober, J.
Schmitt, W.
Blohmer, J-U
Kuemmel, S.
Engels, K.
Lederer, B.
Schneeweiss, A.
Hartmann, A.
Jakisch, C.
Untch, M.
Hanusch, C.
Weber, K.
Loibl, S.
机构
[1] Charite, Berlin, Germany
[2] German Breast Grp, Neu Isenburg, Germany
[3] Helios Klinikum Berlin Buch, Berlin, Germany
[4] Univ Ulm Klinikum, Ulm, Germany
[5] Kliniken Essen Mitte, Essen, Germany
[6] Zentrum Pathol Zytol & Molekularpathol Neuss, Neuss, Germany
[7] Univ Klinikum Heidelberg, Heidelberg, Germany
[8] Univ Klinikum Erlangen, Erlangen, Germany
[9] Sana Klinikum Offenbach, Offenbach, Germany
[10] Rotkreuzklinikum Munchen, Munich, Germany
关键词
D O I
10.1158/1538-7445.SABCS16-S1-09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S1-09
引用
收藏
页数:2
相关论文
empty
未找到相关数据